It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The programmable synthesis of rationally engineered crystal architectures for the precise arrangement of molecular species is a foundational goal in nanotechnology, and DNA has become one of the most prominent molecules for the construction of these materials. In particular, branched DNA junctions have been used as the central building block for the assembly of 3D lattices. Here, crystallography is used to probe the effect of all 36 immobile Holliday junction sequences on self-assembling DNA crystals. Contrary to the established paradigm in the field, most junctions yield crystals, with some enhancing the resolution or resulting in unique crystal symmetries. Unexpectedly, even the sequence adjacent to the junction has a significant effect on the crystal assemblies. Six of the immobile junction sequences are completely resistant to crystallization and thus deemed “fatal,” and molecular dynamics simulations reveal that these junctions invariably lack two discrete ion binding sites that are pivotal for crystal formation. The structures and dynamics detailed here could be used to inform future designs of both crystals and DNA nanostructures more broadly, and have potential implications for the molecular engineering of applied nanoelectronics, nanophotonics, and catalysis within the crystalline context.
Engineered crystal architectures from DNA have become a foundational goal for nanotechnological precise arrangement. Here, the authors systematically investigate the structures of 36 immobile Holliday junction sequences and identify the features allowing the crystallisation of most of them, while 6 are considered fatal.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 Arizona State University, Biodesign Center for Molecular Design and Biomimetics, Tempe, USA (GRID:grid.215654.1) (ISNI:0000 0001 2151 2636)
2 Arizona State University, Biodesign Center for Molecular Design and Biomimetics, Tempe, USA (GRID:grid.215654.1) (ISNI:0000 0001 2151 2636); Arizona State University, School of Molecular Sciences, Tempe, USA (GRID:grid.215654.1) (ISNI:0000 0001 2151 2636)
3 Institute of Biophysics of the Czech Academy of Sciences, Brno, Czech Republic (GRID:grid.418859.9) (ISNI:0000 0004 0633 8512); Czech Advanced Technology and Research Institute (CATRIN), Palacky University Olomouc, Regional Centre of Advanced Technologies and Materials, Olomouc, Czech Republic (GRID:grid.10979.36) (ISNI:0000 0001 1245 3953)